Journal of Nuclear Medicine: 58 (9)

September 1, 2017; Volume 58,Issue 9

Cover image

FEATURED ARTICLE

Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point ¹⁸F-FDG PET/CT Imaging in Patients with Advanced Melanoma. Steve Cho et al. See page 1421.

Can PET/CT predict response to immune checkpoint blockade in melanoma? James Kelly et al. See page 1442.

In this issue

Issue highlights

Prediction of Response to Immune Checkpoint Inhibitor Therapy Using Early-Time-Point ¹⁸F-FDG PET/CT Imaging in Patients with Advanced Melanoma
Dual-Target Binding Ligands with Modulated Pharmacokinetics for Endoradiotherapy of Prostate Cancer
Is Tau Imaging More Than Just Upside-Down ¹⁸F-FDG Imaging?
Operational and Dosimetric Aspects of Pediatric PET/CT

Diagnostic Evaluation of Pulmonary Embolism During the COVID-19 Pandemic
First-in-Humans Imaging with ⁸⁹Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Incidental Findings Suggestive of COVID-19 in Asymptomatic Patients Undergoing Nuclear Medicine Procedures in a High-Prevalence Region
Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention
Molecular Imaging of Fibroblast Activity After Myocardial Infarction Using a ⁶⁸Ga-Labeled Fibroblast Activation Protein Inhibitor, FAPI-04

More...

Main menu

User menu

Search

Table of Contents

Cover image

In this issue

Issue highlights

Jump to